Las Vegas, NV -- (SBWIRE) -- 01/02/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: NovaGold Resources Inc. (USA)(NYSEMKT:NG), G-III Apparel Group, Ltd.(NASDAQ:GIII), Aberdeen Asia-Pacific Income Fund, Inc.(NYSEMKT:FAX), Orexigen Therapeutics, Inc.(NASDAQ:OREX)
NovaGold Resources Inc. (USA)(NYSEMKT:NG) was a volume gainer of 2.44 million shares and the average volume of the stock remained 1.63 million shares. The stock opened the session at $2.41 and finished at the end of the day at $2.54 and the stock escalated 4.10%.The market capitalization of the stock remained 804.32 million. NovaGold Resources Inc. engages in the exploration and development of mineral properties primarily in Alaska, the United States and British Columbia, Canada. The company primarily explores for gold, silver, copper, zinc, and lead ores. It primarily holds interest in the Donlin Gold deposits located in southwestern Alaska covering an area of approximately 81,361 acres.
For How Long NG will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, G-III Apparel Group, Ltd.(NASDAQ:GIII) exchanged 2.42 million shares and the average volume remained 224,212.00 shares. The stock closed the session at $73.96 with the drop of -0.30%. G-III Apparel Group Ltd. designs, manufactures, and markets women?s and men?s apparel primarily in the United States. It provides outerwear, dresses, sportswear, women?s suits, and women?s performance wear; and accessories, such as luggage, women?s handbags, small leather goods, and cold weather accessories.
Why Should Investors Buy GIII After the Recent Fall? Just Go Here and Find Out
Aberdeen Asia-Pacific Income Fund, Inc.(NYSEMKT:FAX) decreased -0.52% and its closing price was $5.76. The volume of the stock was 2.39 million shares and the average volume remained 1.20 million shares. The market capitalization of the stock remained 1.54 billion. The beta of the stock remained 0.45. Aberdeen Asia-Pacific Income Fund, Inc. (the Fund) is a closed-end, non-diversified management investment company. The Fund’s principal investment objective is to seek current income. The Fund may also achieve incidental capital appreciation. Aberdeen Asia-Pacific Income Fund, Inc. invests in Australian and Asian debt securities.
Will FAX Get Buyers Even After The Recent Rally? Find Out Here
Orexigen Therapeutics, Inc.(NASDAQ:OREX) exchanged 2.37 million shares in the previous trading session, and its average trading remained 3.06 million shares. OREX dropped -1.40% and it closed the trading at $5.63. The market capitalization of the stock remained 570.74 million. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include Contrave, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic, which has completed Phase II clinical trials.
Has OREX Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)